{"id":"NCT00317109","sponsor":"GlaxoSmithKline","briefTitle":"Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects","officialTitle":"Booster Vaccination Study to Assess Safety & Reactogenicity of a Dose of DTPw-HBV/Hib Vaccine and to Assess the Immunogenicity, Safety & Reactogenicity of a Dose of Mencevax™ ACW in Subjects Primed in Study 759346/007","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-04-19","primaryCompletion":"2007-05-01","completion":"2007-05-17","firstPosted":"2006-04-24","resultsPosted":"2017-03-01","lastUpdate":"2018-06-06"},"enrollment":168,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Meningococcal"],"interventions":[{"type":"BIOLOGICAL","name":"Tritanrix™- HepB","otherNames":[]},{"type":"BIOLOGICAL","name":"Hiberix™","otherNames":[]},{"type":"BIOLOGICAL","name":"Mencevax™ ACW","otherNames":[]}],"arms":[{"label":"AC primed Group","type":"EXPERIMENTAL"},{"label":"AC unprimed Group","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the safety and reactogenicity of a booster dose of diphtheria-tetanus-whole cell pertussis-hepatitis B virus/Haemophilus influenzae type b vaccine (DTPw-HBV/Hib) at 15-18 m and to assess the immunogenicity, safety, and reactogenicity of a dose of Mencevax™ Group A, C and W135 polysaccharide meningococcal vaccine (ACW) at 24 to 30 m in primed subjects.\n\nThe Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Number of Subjects With Serum Bactericidal Assay Against N. Meningitidis Serogroups A, C Using Rabbit Complement (rSBA-MenA,C) Antibodies","timeFrame":"At one month post vaccination with Mencevax™ ACW vaccine (Month 25-31)","effectByArm":[{"arm":"Tritanrix-HepB/Hiberix Group","deltaMin":65,"sd":null},{"arm":"Tritanrix-HepB/Hiberix-Mencevax AC Group","deltaMin":59,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Months","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":3,"countries":["South Africa"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":82},"commonTop":["Pain","Redness","Loss of appetite","Irritability","Drowsiness"]}}